US · Healthcare

Cannabis Bioscience International Holdings Inc. (CBIH)

Drug Manufacturers - Specialty & Generic

Cannabis Bioscience International Holdings Inc. (CBIH) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for CBIH

P/E ratio
18.00

Cannabis Bioscience International Holdings Inc. (CBIH) — FAQ

What is CBIH's P/E ratio?

The price-to-earnings (P/E) ratio for Cannabis Bioscience International Holdings Inc. (CBIH) is 18.00 (data as of 2026-05-23).

Does Cannabis Bioscience International Holdings Inc. pay a dividend?

Dividend yield is not available in the current snapshot for Cannabis Bioscience International Holdings Inc. (CBIH). Check the MyAverix Finance app for the latest dividend data.

What sector is Cannabis Bioscience International Holdings Inc. in?

Cannabis Bioscience International Holdings Inc. (CBIH) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is CBIH listed on?

CBIH is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play